New clinical trial to test novel approach to treat triple-negative breast cancer
Thursday, June 2, 2011 - 15:30
in Health & Medicine
A multicenter clinical trial will evaluate a new approach to treat triple-negative breast cancer, an often-aggressive type of cancer that is more common among African-Americans and young women. The study will help researchers determine if an experimental drug, entinostat, can reprogram tumor cells to express a protein called an estrogen receptor to make them sensitive to hormone therapy.